Showing results (1351-1360 of 2,297) with videos related to

Sort By:
Pageof 230
Clinical and Experimental Medicine|November 23, 2022
Predictive value of C-reactive protein for disease severity and survival in COVID-19 patients: a systematic review and meta-analysisLihong Chi, Shuai Wang, Xiaoyu Wang, et al.
Clinical and Experimental Medicine|November 24, 2022
Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysisFuxing Zhao, Guoshuang Shen, Qiuxia Dong, et al.
Clinical and Experimental Medicine|November 24, 2022
Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic targetLiqiao Chen, Zizhen Wu, Jiamei Guo, et al.
Clinical and Experimental Medicine|January 24, 2019
TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancerJian-Ang Li, Tiantao Kuang, Ning Pu, et al.
Clinical and Experimental Medicine|November 4, 2019
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control studyM Prete, E Favoino, R Giacomelli, et al.
Clinical and Experimental Medicine|July 9, 2021
The association between serum liver enzymes and cancer mortalitySomaya Albhaisi, Rehan Qayyum
Clinical and Experimental Medicine|July 10, 2021
Pancreatic MR imaging and endocrine complications in patients with beta-thalassemia: a single-center experienceCihangir Sevimli, Yasin Yilmaz, Zuhal Bayramoglu, et al.
Clinical and Experimental Medicine|July 2, 2021
An exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDLAugustin G L Vannier, Amanda PeBenito, Vladislav Fomin, et al.
Clinical and Experimental Medicine|July 3, 2021
Impact of serum soluble CD155 level at diagnosis on interim response to CHOP with or without rituximab in diffuse large B cell lymphomaMohamed Osman Azzazi, Hany Mohamed Hegab, Amro Mohamed Sedky El-Ghammaz, et al.
Clinical and Experimental Medicine|July 18, 2021
RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinomaYue Li, Xiaoqin He, Xiaoyu Zhang, et al.
Pageof 230